Development of a novel shared decision making aid for primary immunodeficiency diseases.
Immunotherapy
; 15(9): 647-656, 2023 06.
Article
in En
| MEDLINE
| ID: mdl-37158075
Shared decision making and developing a decision aid Shared decision making happens when patients and doctors work together to choose treatment options based on a patient's concerns, preferences, goals and values, as well as medical information. The aim of this project was to develop a decision aid to help patients with primary immunodeficiency diseases (PID), in which part of the body's immune system is missing or doesn't function correctly. This will allow patients to better understand and communicate with the healthcare team on their preferences about immunoglobulin treatments, which fight infection by boosting antibody (protein) levels in the blood. The authors talked to experts and reviewed existing information to decide what treatment features the aid should consider. Patients with PID then tested the aid, and changes were made based on their feedback. Doctors specializing in treating PID also provided their feedback. The final aid was judged to be helpful and easy to use by the participants. With further research, this aid could be used to help inexperienced patients better understand what immunoglobulin treatment features are most important to them, and support shared decision-making between patients and their doctors.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Decision Support Techniques
/
Primary Immunodeficiency Diseases
Type of study:
Prognostic_studies
/
Qualitative_research
Aspects:
Patient_preference
Limits:
Adult
/
Humans
Language:
En
Journal:
Immunotherapy
Journal subject:
ALERGIA E IMUNOLOGIA
/
TERAPEUTICA
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom